Home
About
Overview
Sharing Data
ORCID
Help
History (10)
Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer.
A Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision Medicine.
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology.
Celiac Disease and Gluten-Related Disorders.
Differential Distribution of Brain Metastases from Non-Small Cell Lung Cancer Based on Mutation Status.
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Differential Distribution of Brain Metastases from Non-Small Cell Lung Cancer Based on Mutation Status.
Differential Distribution of Brain Metastases from Non-Small Cell Lung Cancer Based on Mutation Status. Brain Sci. 2023 Jul 11; 13(7).
View in:
PubMed
authors with profiles
Ravi Salgia